CCND1 and nasopharyngeal carcinoma: Metformin effectively inhibits nasopharyngeal carcinoma cell proliferation by inducing G1 cell cycle arrest, downregulating cyclin D1, and suppressing mTORC1 signaling through AMPK activation.